It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States
References
- Cuchel M, Raal FJ, Hegele RA, Al-Rasadi K, Arca M, Averna M, et al. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: New treatments and clinical guidance. Eur Heart J. 2023; 44: 2277–91. DOI: 10.1093/eurheartj/ehad197
- Cuchel M, Lee PC, Hudgins LC, Duell PB, Ahmad Z, Baum SJ, et al. Contemporary homozygous familial hypercholesterolemia in the United States: Insights from the CASCADE FH Registry. J Am Heart Assoc. 2023; 12:
e029175 . DOI: 10.1161/JAHA.122.029175 - Tromp TR, Hartgers ML, Hovingh GK, Vallejo-Vaz AJ, Ray KK, Soran H, et al. Worldwide experience of homozygous familial hypercholesterolaemia: Retrospective cohort study. Lancet Lond Engl. 2022; 399: 719–28. DOI: 10.1016/S0140-6736(21)02001-8
- Watts GF, Gidding SS, Hegele RA, Raal FJ, Sturm AC, Jones LK, et al. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nat Rev Cardiol; 2023. DOI: 10.1038/s41569-023-00892-0
- Gidding SS, Hegele RA. Introducing personalized medicine into pediatric homozygous familial hypercholesterolemia care. Arterioscler Thromb Vasc Biol. 2022; 42: 1458–60. DOI: 10.1161/ATVBAHA.122.318598
- Raal FJ, Pilcher GJ, Panz VR, van Deventer HE, Brice BC, Blom DJ, et al. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy. Circulation. 2011; 124: 2202–7. DOI: 10.1161/CIRCULATIONAHA.111.042523
- Representatives of the Global Familial Hypercholesterolemia Community, Wilemon KA, Patel J, Aguilar-Salinas C, Ahmed CD, Alkhnifsawi M, et al. Reducing the clinical and public health burden of familial hypercholesterolemia: A global call to action. JAMA Cardiol. 2020; 5: 217–29. DOI: 10.1001/jamacardio.2019.5173
- Brown L, Ruel I, Baass A, Bergeron J, Brunham LR, Cermakova L, et al. Homozygous familial hypercholesterolemia in Canada. JACC Adv. 2023; 2: 100309. DOI: 10.1016/j.jacadv.2023.100309
- Kasiewicz LN, Biswas S, Beach A, Ren H, Dutta C, Mazzola AM, et al. GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy. Nat Commun. 2023; 14: 2776. DOI: 10.1038/s41467-023-37465-1
- Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva, Switzerland: World Health Organization; 1968.
- Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ Can Med Assoc J. 2018; 190: E422–9. DOI: 10.1503/cmaj.171154
- Gidding SS, Wiegman A, Groselj U, Freiberger T, Peretti N, Dharmayat KI, et al. Paediatric familial hypercholesterolaemia screening in Europe: Public policy background and recommendations. Eur J Prev Cardiol. 2022; 29: 2301–11. DOI: 10.1093/eurjpc/zwac200
- Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019; 139: e1082–143. DOI: 10.1161/CIR.0000000000000625
- Daniels SR, Gidding SS, de Ferranti SD, National Lipid Association Expert Panel on Familial Hypercholesterolemia. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011; 5: S30–37. DOI: 10.1016/j.jacl.2011.03.453
- Li J-J, Zhao S-P, Zhao D, Lu G-P, Peng D-Q, Liu J, et al. 2023 Chinese guideline for lipid management. Front Pharmacol. 2023; 14: 1190934. DOI: 10.3389/fphar.2023.1190934
- Vallejo-Vaz AJ, De Marco M, Stevens CAT, Akram A, Freiberger T, Hovingh GK, et al. Overview of the current status of familial hypercholesterolaemia care in over 60 countries – The EAS familial hypercholesterolaemia studies collaboration (FHSC). Atherosclerosis. 2018; 277: 234–55. DOI: 10.1016/j.atherosclerosis.2018.08.051
- Harada-Shiba M, Ohta T, Ohtake A, Ogura M, Dobashi K, Nohara A, et al. Guidance for Pediatric Familial Hypercholesterolemia 2017. J Atheroscler Thromb. 2018; 25: 539–53. DOI: 10.5551/jat.CR002
- Raal FJ, Bahassi EM, Stevens B, Turner TA, Stein EA. Cascade screening for familial hypercholesterolemia in South Africa: The wits FIND-FH program. Arterioscler Thromb Vasc Biol. 2020; 40: 2747–55. DOI: 10.1161/ATVBAHA.120.315040
- Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne CM, et al. Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel. J Am Coll Cardiol. 2018; 72: 662–80. DOI: 10.1016/j.jacc.2018.05.044
- Wald DS, Bestwick JP, Morris JK, Whyte K, Jenkins L, Wald NJ. Child-Parent familial hypercholesterolemia screening in primary care. N Engl J Med. 2016; 375: 1628–37. DOI: 10.1056/NEJMoa1602777
- McGowan MP, Cuchel M, Ahmed CD, Khera A, Weintraub WS, Wilemon KA, et al. A proof-of-concept study of cascade screening for familial hypercholesterolemia in the US, adapted from the Dutch model. Am J Prev Cardiol. 2021; 6: 100170. DOI: 10.1016/j.ajpc.2021.100170
- Golwala S, Dolin CD, Nemiroff R, Soffer D, Denduluri S, Jacoby D, et al. Feasibility of lipid screening during first trimester of pregnancy to identify women at risk of severe dyslipidemia. J Am Heart Assoc. 2023; 12:
e028626 . DOI: 10.1161/JAHA.122.028626 - Gregg AR, Aarabi M, Klugman S, Leach NT, Bashford MT, Goldwaser T, et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: A practice resource of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 2021; 23: 1793–806. DOI: 10.1038/s41436-021-01203-z
- Gold NB, Adelson SM, Shah N, Williams S, Bick SL, Zoltick ES, et al. Perspectives of Rare Disease Experts on Newborn Genome Sequencing. JAMA Netw Open. 2023; 6:
e2312231 . DOI: 10.1001/jamanetworkopen.2023.12231 - Carlson LM, Vora NL. Prenatal diagnosis: Screening and diagnostic tools. Obstet Gynecol Clin North Am. 2017; 44: 245–56. DOI: 10.1016/j.ogc.2017.02.004
- Tromp TR, Reijman MD, Wiegman A, Hovingh GK, Defesche JC, Van Maarle MC, et al. Counseling couples at risk of having a child with homozygous familial hypercholesterolemia – Clinical experience and recommendations. J Clin Lipidol. 2023; 17: 291–6. DOI: 10.1016/j.jacl.2022.12.006
- Boyle CA, Bocchini JA, Kelly J. Reflections on 50 years of newborn screening. Pediatrics. 2014; 133: 961–3. DOI: 10.1542/peds.2013-3658
- Watson MS, Mann MY, Lloyd-Puryear MA, Rinaldo P, Howell RR. Newborn screening: toward a uniform screening panel and system – Executive Summary. Genet Med. 2006; 8: S1–11. DOI: 10.1097/01.gim.0000223891.82390.ad
- Held PK, Campbell K, Wiberley-Bradford AE, Lasarev M, Horner V, Peterson A. Analytical validation of familial hypercholesterolemia biomarkers in dried blood spots. Int J Neonatal Screen. 2022; 8: 14. DOI: 10.3390/ijns8010014
- Held PK, Lasarev M, Zhang X, Wiberley-Bradford AE, Campbell K, Horner V, et al. Familial hypercholesterolemia biomarker distribution in dried blood spots. J Pediatr. 2023; 259: 113469. DOI: 10.1016/j.jpeds.2023.113469
- Taageby Nielsen S, Mohr Lytsen R, Strandkjær N, Juul Rasmussen I, Sillesen A-S, Vøgg ROB, et al. Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life. Eur Heart J. 2023; 44: 4408–18. DOI: 10.1093/eurheartj/ehad547
- Prosser LA, Grosse SD, Kemper AR, Tarini BA, Perrin JM. Decision analysis, economic evaluation, and newborn screening: challenges and opportunities. Genet Med. 2012; 14: 703–12. DOI: 10.1038/gim.2012.24
- De Ferranti SD, Daniels SR, Gillman M, Vernacchio L, Plutzky J, Baker AL. NHLBI integrated guidelines on cardiovascular disease risk reduction: Can we clarify the controversy about cholesterol screening and treatment in childhood? Clin Chem. 2012; 58: 1626–30. DOI: 10.1373/clinchem.2012.182089
- Ross LF, Clayton EW. Ethical issues in newborn sequencing research: The case study of babyseq. Pediatrics. 2019; 144:
e20191031 . DOI: 10.1542/peds.2019-1031
DOI: https://doi.org/10.5334/gh.1316 | Journal eISSN: 2211-8179
Language: English
Submitted on: Mar 1, 2024
Accepted on: Mar 6, 2024
Published on: May 3, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2024 Samuel S. Gidding, Christie M. Ballantyne, Marina Cuchel, Sarah de Ferranti, Lisa Hudgins, Allison Jamison, Mary P. McGowan, Amy L. Peterson, Robert D. Steiner, Melissa K. Uveges, Yunshu Wang, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.